🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

SHE "Nothing in life is to be feared, it is only to be understood."

amazing thanks for the support 🥳 sharing is caring 🥰 koc.ca1.qualtrics.com/jfe/form/SV_0U…

congrats Edi 🥳 let's see how this new SLN concept find its own version in other cancers #GynOnc GYN Cancer | #GYNCSM SoMe4GynOnc OncoAlert

Amazing opportunity 🥳 Fotopoulou/Cunnea Ovarian Cancer Research group & my amazing mentor Prof Taskiran 🇹🇷 ESGO European Network of Young Gynae Oncologists GYN Cancer | #GYNCSM SoMe4GynOnc

🚨Is Fertility Preservation an Option in Unconventional Situations? with Prof Nadeem R. Abu-Rustum💐 🎥 m.youtube.com/watch?v=qDSgG0… 👋 Stay tuned for the fulltext publication IJGC Prof. Dr. İlker Kahramanoğlu European Network of Young Gynae Oncologists ESGO OncoAlert GYN Cancer | #GYNCSM @GynMe4@OncoAlert Team Ovary, Memorial Sloan Kettering Cancer Center

Fantastic discussion with Nadeem R. Abu-Rustum Esra Bilir, MD, MSc Prof. Dr. İlker Kahramanoğlu on the incredibly important topic of oncofertility in unconventional circumstances. MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center

Great pleasure and honor to interview Nadeem Abu-Rustum - Esra Bilir, MD, MSc Prof. Dr. İlker Kahramanoğlu IJGC oncodaily.com/blog/esra-bili… #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews #IJGC #ENYGO

🚨Oncofertility an Option in Unconventional Situations Prof Abu-Rustum & Prof Kahramanoglu & Dr Bilir Link: buff.ly/nhsXPt8

👩🏽‍⚕️Many female doctors are still asked if we are the doctors even with🥼or introducing ourselves as 'Dr' I used to get upset...now I ask 'Why do you ask that?' The patients say 'you look too young to be a doc' & we laugh together😆🥰 #LoveWhatYouDoDoWhatYouLove Women In Medicine®

#gyncsm

📢spread the news & visit now ovarian.gynecancer.org 🗺️available in many languages #OvarianCancer ESGO European Network of Young Gynae Oncologists ENGAGe.ESGO World Gynecologic Oncology Day SoMe4GynOnc GYN Cancer | #GYNCSM OncoAlert OncoDaily Fotopoulou/Cunnea Ovarian Cancer Research group World Ovarian Cancer Day & WOCCoalition AstraZeneca Deutsche Stiftung Eierstockkrebs Eierstockkrebs Deutschland e. V. IJGC

Dreams are meant to come true 🏎️ E.B. “You cannot describe passion, you can only live it.” Enzo Ferrari ✍🏼 OR is undescribable passion for me👩🏽‍⚕️ ❣️Ferrari 488 Pista 🎯 Ferrari Roma

Thrilled to share AAGL news on JMIG social media scholars 2025 🚀 yeap there are 2 Esra's in the group😅 Esra Cetin @fmigs1 newsscope.aagl.org/volume-39-issu…

June Issue: Combination Treatment with Spacer Placement Surgery Followed by Particle #Radiotherapy for Lymph Node Metastasis from #UterineCancer rdcu.be/epMxc Esra Bilir, MD, MSc Syed A. Ahmad

𝘁𝗵𝗮𝘁'𝘀 𝘁𝗵𝗲 𝗗 𝗘 𝗗 𝗜 𝗖 𝗔 𝗧 𝗜 𝗢 𝗡 & 𝗿𝗲𝗮𝗹 𝗛 𝗔 𝗥 𝗗 𝗪𝗼𝗿𝗸🥳🧿 🎆 Top 10 in #OBGYN ESGO IGCS European Network of Young Gynae Oncologists Pedro T Ramirez René Pareja Fotopoulou/Cunnea Ovarian Cancer Research group Anna Fagotti Ane Gerda Z Eriksson MD PhD Nicolò Bizzarri SoMe4GynOnc GYN Cancer | #GYNCSM OncoAlert OncoDaily

Esra Bilir, MD, MSc ESGO IGCS European Network of Young Gynae Oncologists Pedro T Ramirez René Pareja Fotopoulou/Cunnea Ovarian Cancer Research group Anna Fagotti Ane Gerda Z Eriksson MD PhD Nicolò Bizzarri SoMe4GynOnc GYN Cancer | #GYNCSM OncoAlert We would like to inform you that your post has been published on OncoDaily.com. Thank you for sharing! oncodaily.com/blog/impact-fa…

JAMA review: Ovarian cancer often silent, mostly found late. 80% diagnosed at advanced stage. Early stage: surgery + chemo, 5-year survival up to 95%. Advanced: surgery, chemo, then maintenance. PARP inhibitors offer hope, especially for BRCA+ patients. #ovariancancer